🔎 Trials Near Me

Utama › Kanser Endometrium › Maine

Kajian klinikal Kanser Endometrium di Maine

7 kajian untuk Kanser Endometrium sedang mencari peserta di lokasi di Maine.

Bandar di Maine

Teks kajian rasmi (Bahasa Inggeris)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • Harold Alfond Center for Cancer Care, Augusta
  • Lafayette Family Cancer Center-EMMC, Brewer
  • MaineHealth Maine Medical Center- Scarborough, Scarborough
  • dan 1 lagi
Mengambil pesertaFasa 2
Semua umur · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05564377

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

  • Lafayette Family Cancer Center-EMMC, Brewer
  • MaineHealth Maine Medical Center- Scarborough, Scarborough
Mengambil pesertaFasa 3
Umur 18 ke atas · Wanita · Dikemas kini 2 Okt 2026 · NCT07198074

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

  • MaineHealth Maine Medical Center- Scarborough, Scarborough
Mengambil pesertaFasa 2
Umur 18 ke atas · Wanita · Dikemas kini 28 Sep 2026 · NCT05112601

Endometrial Cancer Vaginal Fluid Specimen Collection Study

  • MaineHealth, Scarborough
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Wanita · Dikemas kini 27 Ogo 2026 · NCT07544680

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

  • Research Site, Scarborough
Mengambil pesertaFasa 3
Umur 18 ke atas · Wanita · Dikemas kini 29 Jul 2026 · NCT07044336

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Scarborough
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.